EGR2 plays a key role in the PTEN-induced apoptotic pathway. Using adenovirus-mediated gene transfer to 39 cancer cell lines, we found that EGR2 could induce apoptosis in a large proportion of these lines by altering the permeability of mitochondrial membranes, releasing cytochrome c and activating caspase-3, -8, and -9. Analysis by cDNA microarray and subsequent functional studies revealed that EGR2 directly transactivates expression of BNIP3L and BAK. Our results helped to clarify the molecular mechanism of the apoptotic pathway induced by PTEN-EGR2, and suggested that EGR2 may be an excellent target molecule for gene therapy to treat a variety of cancers.
Introduction
Mutations of the PTEN gene have been found in human cancers arising from various organs including uterine endometrium, breast, ovary, prostate, and brain (Li et al., 1997b; Risinger et al., 1997; Steck et al., 1997; Obata et al., 1998) . Although most tumor suppressors appear to be involved directly in regulation of the cell cycle, PTEN is located in cytoplasm and regulates cell growth through its function as a phosphatase; that is, it modulates the phosphatidylinositol-3-kinase pathway by catalyzing degradation of the phosphatidylinositol(3,4,5)triphosphate generated by phosphatidylinositol-3-kinase. Since this process is involved in various pathways that transfer signals into the nucleus, it is not easy to determine all the mediators involved in PTEN's growth-suppressive and apoptosis-inducing activities.
To identify additional mediators of the PTEN pathway, we previously carried out cDNA microarray analyses (Matsushima-Nishiu et al., 2001) and selected eight candidate genes (Ono et al., 2000; Unoki and Nakamura, 2001) . Further biological analysis to determine the effects of these eight gene products on cell growth revealed that the EGR2 protein was likely to be an important mediator of the PTEN growth-suppressive signaling pathway ). Induced expression of EGR2 using a plasmid vector was able to suppress cell growth significantly in several cancer-derived cell lines, while inhibition of endogenous EGR2 expression using antisense oligonucleotides accelerated cell growth.
The Egr2/Krox-20 gene was originally identified as a serum response immediate-early gene encoding a protein with three Cys 2 -His 2 -type zinc-finger motifs (Chavrier et al., 1988) . Egr2/Krox-20 (À/À) mice display disrupted hindbrain segmentation and development, and differentiation of Schwann cells is blocked at an early stage (Topilko et al., 1994) . In human, defects of this gene cause congenital hypomyelinating neuropathy and type 1 Charcot-Marie-Tooth syndrome (Warner et al., 1998) . Egr2/Krox-20 is also associated with the onset of myelination in the peripheral nervous system (Zorick et al., 1996) .
No association between EGR2 and PTEN has been reported to date, except in a study using Egr2/Krox-20 as a hindbrain marker in Pten-deficient mouse embryos. At embryonic stage E8.5 of mice with homozygous deletions of Pten, the cephalic region was severely overgrown and abnormal Egr2/Krox-20 expression occurred on one side of the prospective forebrain (Suzuki et al., 1998) . This observation provided indirect evidence that Egr2/Krox-20 expression was regulated by PTEN in vivo.
We report here that exogenous expression of EGR2 using AdCAEGR2 can induce apoptosis significantly in various cancer cell lines by altering the permeability of mitochondrial membranes, releasing cytochrome c and activating caspase-3, -8, and -9. We also describe evidences that EGR2 directly induces expression of two proapoptotic proteins of the Bcl-2 family, BNIP3L and BAK, which are localized at mitochondria (Chittenden et al., 1995; Farrow et al., 1995; Kiefer et al., 1995; Matsushima et al., 1998; Imazu et al., 1999; Shimizu et al., 1999) . These results bring to light novel mechanisms of apoptosis induced by PTEN-EGR2, and indicate that EGR2 is potentially a useful molecule for gene therapy to treat a wide range of cancers.
Results

Adenoviral-mediated gene transfer and expression of EGR2
We constructed an adenovirus designed to express EGR2 (AdCAEGR2) and performed immunoblotting with anti-Egr2 antibody to examine expression of EGR2 in cancer-derived cells. EGR2 protein was detected in cells infected with AdCAEGR2 as early as 6 h after infection, but did not occur in cells infected with AdCALacZ (Figure 1a) . No endogenous EGR2 protein was detectable at hour zero in the cells examined.
To examine growth-suppressive effects of exogenous EGR2 in various cell lines, we first evaluated the efficiency of adenovirus-mediated gene transfer by X-Gal (5-bromo-4chloro-3-indolyl-b-d-galactopyranoside) staining of cells infected with AdCALacZ at MOI 100. As summarized in Table 1 , 24 h after infection, the proportions of b-gal-positive cells for all 39 of the cancer-derived cell lines were very high (more than 50%).
Subsequently, we examined the effect of AdCAEGR2 infection on cell death at 25, 50, and 100 MOI. Table 1 shows averages of the proportion of viable cells that were infected with AdCALacZ or AdCAEGR2 at 100 MOI. For 33 of the 39 lines (84.6%), exogenous expression of EGR2 decreased cell viability at significantly high levels (indicated by MTT dye conversion) as compared to cells infected with AdCALacZ ( Figure 1b) ; apoptosis was observed at 48-60 h after AdCAEGR2 infection. The remaining six cell lines (indicated as sensitivities M and R in Table 1 ) were relatively resistant to EGR2 exogenous expression; cell death was induced in a very small proportion of those cells. Induction of cell death by AdCAEGR2 infection was not related to the mutational status of PTEN, p53, APC, BAX, or hMSH2 (Table 1 ). The relative level of endogenous EGR2 expression in each cell line was examined by quantitative RT-PCR using the average level among 18 normal adult tissues as a baseline (Table 1) . Expression in almost all cancer cell lines was less than that in normal tissues. We examined genetic alterations of the EGR2 promoter region in several of the cell lines whose endogenous EGR2 expression was very low, but somatic mutations were not observed in any of the cells examined (data not shown).
Apoptosis induced by EGR2 through activation of caspase-3, -8, and -9
To analyse the EGR2-mediated death of cancer cells further, we performed flowcytometry using six of the cancer cell lines, SW480, TYK-nu, HEC-88, U87MG, A172, and LNCap.FGC. Induction of EGR2 expression significantly increased the numbers of cells at Sub-G 1 in the four lines that were EGR2-sensitive (SW480, TYKnu, HEC-88, and U87MG), but not in EGR2-resistant A172 and LNCap.FGC (Figure 2a) . By TUNEL assay we observed that the population of apoptotic cells among AdCAEGR2-infected EGR2-sensitive cells was significantly greater than that in AdCALacZ-infected cells, but this was not the case in the resistant lines (Figure 2b) .
Subsequently, activities of caspase-3, -8, and -9 were examined by spectrophotometric detection of the chromophore p-nitroanilide (pNA) after cleavage from the labeled substrate-pNA. Caspase-3 and -9 activities elevated two times higher 24 h after the AdCAEGR2 infection. On the other hand, caspase-8 activation occurred much later (Figure 2c) . Degradation of procaspase-3, -8, and -9, and production of active forms of these caspases were confirmed by Western blotting (Figure 2d ).
Analysis by cDNA microarray using AdCAEGR2
To investigate further the molecular mechanism of EGR2-mediated cell death, we analysed expression profiles of SW480 cells using cDNA microarrays consisting of 4608 genes. As shown in Table 2 , a number of genes were significantly upregulated in cells infected with AdCAEGR2, a result confirmed by semiquantitative RT-PCR (data not shown). The upregulated genes included mitochondrial proapoptotic proteins of the Bcl-2 family such as BNIP3L/NIX (Imazu et al., 1999) , BAK , BAD (Yang et al., 1995) , and NGFR (NGF receptor TNF receptor superfamily member 16), a TNF receptor (Rabizadeh et al., 1993) . To verify whether upregulation of these genes was important for the apoptotic event in cancer cells, we infected AdCAEGR2 into four EGR2-sensitive cell lines, SW480, TYK-nu, Ishikawa3-H-12 and U87MG, and two EGR2-resistant cell lines, A172 and LNCap.FGC. Then semiquantitative RT-PCR experiments were performed. As shown in Figure 3a , exogenous EGR2 induced expression of BNIP3L and BAK genes in all four EGR2-sensitive cell lines, but not in the EGR2-resistant lines. Expression of BAD was induced in two of the four EGR2-sensitive cell lines, and NGFR was induced in all six of the cell lines examined. These results indicated that BNIP3L and BAK are likely to play crucial roles in the EGR2-induced cell-death pathway.
We also examined expression of some related genes, BNIP3/NIP3, BAX, BID, and TNFa, that were not spotted on our microarray slide (Figure 3a) . Expression of BNIP3, an isologue of BNIP3L (Chen et al., 1999) , was induced in two EGR2-sensitive cell lines. Expression of BID, which interacts with BAK (Wei et al., 2000) , and of BAX, a major transcriptional target of p53 (Miyashita et al., 1994) , was not induced by exogenous EGR2. Since caspase-8 activity is induced by EGR2, some have suggested that a death ligand/receptormediated pathway might be activated (Kruidering and Evan, 2000) . We found that infection with AdCAEGR2 could induce expression of only NGFR (Rabizadeh et al., 1993) and TNFa (Baker and Reddy, 1998) Fas ligand (TNFSF6) were reported to be induced by EGR2 in lymphocytes (Mittelstadt and Ashwell, 1999) , the Fas ligand was not induced by EGR2 in our experiment. Expression of NGFR was induced in all the cell lines described above, whereas TNFa was induced only in EGR2-sensitive cell lines. Two TNFa receptors, TNFRSF1A and 1B (Baker and Reddy, 1998) , were expressed stably or induced by EGR2 in the sensitive cell lines. Induction was confirmed by Western blotting with respect to both dimer and monomer forms of BNIP3L, BAK, and both hyper-(inactive) and hypophosphorylated (active) forms of BAD in SW480 and TYK-nu cells ( Figure 3b) .
The cDNA microarray analysis also revealed that many other downstream genes were upregulated by EGR2, for example, cell-cycle-associated genes such as ephrin-A1 (EFNA1) and interferon regulatory factor 1 (IRF1); two tumor suppressors, exostoses 1 (EXT 1) and inhibin alpha (INHA); transcription factors such as activating transcription factor 3 (ATF3) and general transcription factor IIB (GTF2b); as well as various signal transducers including hematopoietic cell-specific Lyn substrate 1 (HCLS1) and regulator of G-protein signaling 3 (RGS3); Table 2 .
Release of mitochondrial cytochrome c and alteration of membrane permeability by EGR2 Some proapoptotic proteins of the Bcl-2 family, including BNIP3L (Imazu et al., 1999) , BAK , and BAD (Yang et al., 1995) , target mitochondria directly and induce loss of membrane potential EGR2 induces apoptosis by transactivation of BNIP3L and BAK M Unoki and Y Nakamura and release of cytochrome c; therefore, we examined mitochondrial changes during EGR2-induced apoptosis. Release of cytochrome c from mitochondria to cytoplasm occurred in three EGR2-sensitive cell lines examined, SW480, Ishikawa3-H-12, and TYK-nu (Figure 4a left: see * ). On the other hand, no release was observed in the EGR2-resistant lines, A172 and LNCap.FGC. To confirm fractionation, we detected mitochondria using mitochondria-specific antibody (Figure 4a right) . Subsequently, we examined alteration of mitochondrial membrane permeability and found that AdCAEGR2 infection induced loss of membrane potential in all of the three EGR2-sensitive cell lines but not in the resistant cell lines (Figure 4b ).
Direct regulation of BNIP3L and BAK expression by EGR2
We then performed reporter and electromobility-shift assays (EMSA) to investigate whether EGR2 directly transactivates BNIP3L and BAK. We found six possible EGR2-binding sequences (Chavrier et al., 1990; Nardelli et al., 1991; Sham et al., 1993) in the promoter region (À1 to À349) of the BNIP3L gene and two in the promoter region (À18 to À338) of the BAK gene. Figure 5a illustrates the construction of reporter plasmids in which various lengths of the promoter regions of BNIP3L (P1-P6) and BAK (P1-P3) were subcloned into pGL3-basic vector. Figure 5b summarizes results of the reporter-gene assay, indicating EGR2 induces apoptosis by transactivation of BNIP3L and BAK M Unoki and Y Nakamura that BNIP3L and BAK are direct transcriptional targets of EGR2 and that two genomic segments (À140 to À148 and À32 to À40) in the BNIP3L promoter region and a segment (À263 to À271) in the BAK promoter region are possible candidates for EGR2-binding motifs. Our EMSA experiments using a nuclear extract from SW480 cells infected with AdCAEGR2 and 25-bp double-stranded DNA probes corresponding to the possible EGR2-binding motifs (Figure 5c ) revealed that EGR2 was able to bind to the candidate-2 sequence (À63 to À71), but not to the candidate-1 sequence (À140 to À148) in the BNIP3L promoter region. It also bound to the candidate sequence (À263 to À271) in the BAK promoter region (Figure 5d ). The construct (mt Â 4) containing a three-nucleotide substitution within the binding motif showed significantly low transactivation activity compared with the wild-type (wt) construct (wt Â 4) in the reporter-gene assay (Figure 5b ), supporting the conclusion that these two apoptosis-related genes are direct transcriptional targets of EGR2.
Discussion
PTEN suppresses cell growth and in some cases induces apoptosis through its function as a phosphatase, but the molecular mechanism by which PTEN mediates cellcycle arrest or apoptosis after its signal(s) are transferred into the nucleus is not well understood. To clarify this molecular process, we performed cDNA microarray analysis using an adenovirus vector designed to express PTEN and identified two novel candidates, BPOZ and Plabeled DNA probes containing wt putative EGR2-binding elements present in the BNIP3L or BAK promoters. No complex of EGR2 protein with the probe containing candidate-1 in the BNIP3L promoter was detected (Lane 1), but the probe containing candidate-2 in this promoter did form a complex with EGR2. The probe containing the candidate binding site in the BAK promoter, and EGR2 protein, was detected as shifted bands (Lanes 3 and 7) that were supershifted by the addition of anti-Egr2 antibody (Lanes 6 and 10). Excess amounts of unlabeled wt DNAs or mutant DNAs were used for the competition experiments (Lanes 2, 4, 5, 8, and 9) EGR2 induces apoptosis by transactivation of BNIP3L and BAK M Unoki and Y Nakamura EGR2, which were able to mediate the growthsuppressive signal of the PTEN pathway (Unoki and Nakamura, 2001). EGR2 was previously reported as a transcriptional factor regulating myelination in the peripheral nervous system (Topilko et al., 1994) ; defects of this gene cause myelinopathies in humans (Warner et al, 1998) , but no role in carcinogenesis was reported previously.
To examine a possible biological function of EGR2 in growth arrest or apoptosis, we constructed adenovirus-EGR2 and transfected it to various cancer cell lines. Among the 39 lines examined, EGR2 induced apoptosis in all but six. Endogenous expression of EGR2 in most of the cancer cell lines, examined by real-time PCR, was lower than in normal tissues. We excluded the possibilities of genetic somatic mutation in EGR2 gene by sequencing.
To investigate the molecular mechanism of the EGR2-mediated cell-death pathway, we performed functional analyses of other genes that were transactivated by infection with AdCAEGR2. These experiments showed that two apoptosis-related genes, BNIP3L and BAK, are direct targets of EGR2 and play important roles in the EGR2-induced apoptotic pathway. BNIP3L and BAK localize in mitochondria and induce apoptosis by interaction with Bcl-2/Bcl-x L , altering mitochondrial membrane permeability and releasing cytochrome c (Imazu et al., 1999; Shimizu et al., 1999; Sattler et al., 1997) . Released cytochrome c leads to the formation of 'apoptosomes' consisting of cytochrome c, Apaf-1, and procaspase-9 (Li et al., 1997a) . Autoactivation of procaspase-9 subsequently activates effector caspases, for example, caspase-3, and kills cells. In our experiments with EGR2, we detected alteration of membrane permeability and release of cytochrome c from mitochondria, as well as activation of caspase-9 and -3. Therefore, we consider that EGR2 induces apoptosis via mitochondrial change through transactivation of BNIP3L and BAK.
We also observed that activation of caspase-8 occurred slightly after the activation of caspase-9 and -3. Caspase-8 mediates death signals generated at the cell membrane by death receptors such as TNFa receptor and Fas (Ashkenazi and Dixit, 1999) . Although Fas ligand was reported to be induced by EGR2 in lymphocytes (Mittelstadt and Ashwell, 1999) , it was not induced in our experiment using cancer cell lines. The difference might be because of the difference in types of cells used in the two studies. Regarding TNFa and its two receptors, TNFRSF1A was constitutively expressed in all six of the cancer cell lines examined in our experiment, while TNFa was induced in the four EGR2- Figure 6 Schematic model for the EGR2-mediated cell-death pathway EGR2 induces apoptosis by transactivation of BNIP3L and BAK M Unoki and Y Nakamura sensitive cell lines infected with AdCAEGR2, but not in the two resistant lines. TNFRSF1B was constitutively expressed in SW480 and was inducible in the remaining three EGR2-sensitive cell lines, but not in the two resistant cell lines. However, since the transactivation of TNFa occurred at a relatively late stage, we suspect that the mitochondria-mediated pathway involving activation of BNIP3L and BAK is the main cell-death pathway induced by EGR2, and that the death ligand/ receptor pathway is likely to play some additional role. NGFR, a TNF receptor having low affinity for NGF, was also induced by EGR2. Expression of NGFR can induce neural cell death (Minaguchi et al., 1999) , and the presence of this receptor enhances TNF-induced apoptosis although TNFa is unable to bind to NGFR (MacEwan, 1996) . Since NGFR was induced in all of our cell lines, whether EGR2-sensitive or -resistant, its role in the EGR2-induced death pathway, if any, remains unclear.
On the basis of the results described here, we propose the model of the EGR2-mediated cell-death pathway shown in Figure 6 . PTEN induces expression of EGR2, and then EGR2 directly transactivates expression of BNIP3L and BAK. BNIP3L and BAK can release cytochrome c from mitochondria, alter mitochondrial membrane permeability, activate caspase-9, and then activate caspase-3. Finally, activated caspase-3 cleaves various substrates and induces apoptosis; the TNFamediated pathway may enhance this mitochondriamediated process. As EGR2 induced cell death efficiently in the majority of cancer cell lines we examined, we believe that EGR2 should be an excellent target molecule for potential gene therapy.
Materials and methods
Cell lines and culture conditions
All endometrial cancer, ovarian cancer, and hepatoma cell lines, as well as colon cancer lines SW480, LoVo, and HCT116, were obtained and maintained as described previously (Minaguchi et al., 1999; Satoh et al., 2000; Matsushima-Nishiu et al., 2001; Unoki and Nakamura, 2001) . A172, A549, H1299, LS174 T, HT-29, DBTRG-05MG, U373MG, U87MG, LNCap.FGC, and PC-3 were obtained from the American Type Culture Collection (Manassas, VA, USA). LU99A and MKN74 were obtained from the Japanese Collection of Research Bioresources (Tokyo, Japan). All cell lines were grown in monolayers in appropriate media supplemented with 10% fetal bovine serum: Eagle's minimal essential medium for A172, DBTRG-05MG, U87MG, and U373MG; F12 medium for PC-3; Dulbecco's modified Eagle's medium for LS174T; and RPMI 1640 for A549, LU99A, H1299, MKN74, LNCap.FGC, and HT-29.
Construction of recombinant adenovirus
To construct AdCAEGR2 viral vectors, a 1.4-kb fragment of EGR2 was cloned into the Swal site of cosmid pAxCAwt (TaKaRa, Tokyo, Japan). Recombinant adenovirus was constructed, propagated, purified, and titered as described previously (Minaguchi et al., 1999) . As a control, AdCALacZ viruses encoding the b-gal gene under the control of the CAG promoter were constructed from the control cosmid pAxCALacZ (TaKaRa). The efficiency of adenovirus-mediated gene transfer was assessed by a b-gal transduction assay described previously (Minaguchi et al., 1999) .
Immunodetection of EGR2, BNIP3L, BAK, and BAD proteins
Proteins extracted from SW480 cells infected with 50 MOI of AdCALacZ or AdCAEGR2 were separated by 12% SDS-PAGE and immunoblotted with rabbit polyclonal antibody to mouse Egr2 (amino acids 8-95; 98% homologous to human in this region; PRB-236P; BabCO, Richmond, CA, USA). To detect BNIP3L, BAK, and BAD, cellular proteins from SW480 and TYK-nu cells were separated by 15% SDS-PAGE and immunoblotted with rabbit polyclonal antibody to human BNIP3L (PC525; Oncogene Research Products, Boston, MA, USA), rabbit polyclonal antibody to human BAK (66026E; BD Biosciences Pharmingen, San Diego, CA, USA), or rabbit polyclonal antibody to human BAD (H-168; Santa Cruz Biotechnology, Santa Cruz, CA, USA). HRP-conjugated antirabbit IgG (Santa Cruz Biotechnology) served as the secondary antibody for the ECL Detection System (Amersham Pharmacia, Piscataway, NJ, USA).
Growth assay
Cell growth was assessed by MTT dye conversion as described previously (Matsushima-Nishiu et al., 2001 ) with minor modifications. Cells were seeded at 1 Â 10 5 cells/well in six-well culture plates and infected with AdCAEGR2 or AdCALacZ at MOIs of 25, 50, or 100. After 48-72 h, virus-containing medium was removed and MTT (5 mg/ml in PBS) was added.
Real-time quantitative PCR
cDNAs were analysed quantitatively for expression of EGR2 by means of a reported fluorogenic 5 0 -nuclease PCR assay (Holland et al., 1991) . Specific primers (Forward: 5 0 -TCTTTCCCAATGCCG-3 0 and Reverse: 5 0 -GGAGATCCAA CGACCTCTTCTCT-3 0 ) and probes (5 0 -TTGATCATGC-CATCTCCGGCCACT-3 0 ) were obtained from Applied Biosystems. Gene-specific PCR products were measured continuously with an ABI PRISM 7700 Sequence Detection System (Applied Biosystems, Foster City, CA, USA) during 40 cycles. GAPDH was used for normalization using predeveloped TaqMan Assay reagents (4310884E, Applied Biosystems).
Flow cytometry and TUNEL assay
Cells were plated at a density of 5 Â 10 5 cells/100-mm dish and infected with 100 MOI of AdCAEGR2 or AdCALacZ. After 48 h (TYK-nu and HEC-88) or 72 h (SW480, U87MG, A172, and LNCap.FGC), cells were harvested and treated with Cycle TEST PLUS (Becton Dickinson, San Jose, CA, USA) according to the manufacturer's protocol. Flow cytometry was performed as described previously (Matsushima-Nishiu et al., 2001) . Apoptotic cells were detected by fluorescence microscopy (TUNEL assay) using the ApopTagkit (Intergen, Purchase, NY, USA) according to the manufacturer's protocol.
Detection of caspase-3, -8, and -9 activities by means of a colorimetric protease assay and Western blotting A colorimetric protease assay kit (Medical & Biological Laboratories, Nagoya, Japan) was used to detect activities of EGR2 induces apoptosis by transactivation of BNIP3L and BAK M Unoki and Y Nakamura caspase-3, -8, and -9. The assay is based on the spectrophotometric detection of the chromophore pNA after cleavage from the labeled substrate-pNA. The substrate for caspase-3 (and -7) was DEVD (Asp-Glu-Val-Asp), that for caspase-8 was IETD (IIe-Glu-Thr-Asp), and that for -9 was LEHD (Leu-Glu-His-Asp). The light emission of pNA was quantified using a microplate reader (BIORAD, Randolph, MA, USA) at 405 nm. The assay was performed according to the manufacturer's protocol. For Western blotting, we used mouse monoclonal antibody to human caspase-3 (19; Medical & Biological Laboratories), mouse monoclonal antibody to human caspase-8 (5F7; Medical & Biological Laboratories), and mouse monoclonal antibody to human caspase-9 (5B4; Medical & Biological Laboratories) for the detection of procaspase-3, -8, and -9 proteins, respectively. cDNA microarray analysis SW480 cells growing in monolayers were infected with AdCAEGR2 or AdCALacZ at 50 MOI. After 6, 12, 24, and 48 h, total RNAs were extracted with Trizol reagent (Gibco, Rockville, MD, USA), treated with DNase I (Roche, Indianapolis, IN, USA) and purified twice by means of spun columns containing oligo (dT)-cellulose (mRNA Purification Kit, Amersham Pharmacia). The isolated mRNAs were amplified, labeled, and hybridized on cDNA-spotted glass slides as described elsewhere (Ono et al., 2000) .
Semiquantitative RT-PCR
Cells were infected with 50 MOI of MCAEGR2 or AdCALacZ and harvested after 12, 24, and 48 h. Total RNAs were isolated using Trizol reagent (Gibco) and treated with DNase I. Equal amounts of RNAs were reverse-transcribed and amplified by the PCR for 20-35 cycles with gene-specific primers at 941C for denaturing, 551C for annealing, and 721C for extension. As an internal control, amplification of GAPDH was carried out by RT-PCR using specific primers (Forward: 5 0 -TGGGT GTGAACCATGAGAAG-3 0 and Reverse: 5 0 -GTGTCGCTG TTGAAGTCAGA-3 0 ).
Detection of cytochrome c release
Cells infected with 50 MOI of AdCAEGR2 or AdCALacZ for 48 h (TYK-nu and Ishikawa3-H-12) or 72 h (SW480, A172, and LNCap.FGC) were separated into mitochondria and other fractions using digitonin (Wako, Osaka, Japan). To confirm fractionation, mouse monoclonal antibody to human mitochondria (MAB1273; CHEMICON, Temecula, CA) was served as positive control. To detect cytochrome c, fractionated proteins (15 mg) were separated by 15% SDS-PAGE and immunoblotted with rabbit polyclonal antibody to human cytochrome c (sc-7159, Santa Cruz, Biotechnology). Reporter assay pGL3-basic vector (Promega, Madison, WI, USA) was used for the luciferase expression assay. Various lengths of the promoter regions of BNIP3L and BAK (Figure 5a ) as well as four copies of the 25-bp fragment corresponding to the wild form or the mutant form of EGR2-binding site were inserted into the vector's cloning site. The cells were infected with 50 MOI of AdCAEGR2 or AdCALacZ, 3 h before transfection of the reporter constructs into SW480. A plasmid vector, pRL-TK (Promega), was cotransfected with each reporter construct using FuGENEt6 Transfection Regent (Roche) according to the supplier's recommendations. After 48 h, the reporter assays were carried out using the Dual-Luciferase Reporter Assay System (Promega) according to the manufacturer's protocol.
Mitochondrial membrane potential
Electromobility-shift assay (EMSA)
SW480 cells infected with AdCAEGR2 were harvested 36 h later, and nuclear extracts were prepared. The extracts were incubated for 30 min at 41C with 200 pg of sonicated salmon sperm DNA, 10 ng BSA, 6 mm HEPES (pH 7.6), 6% glycerol, 3 mm NaCl, 0.45 mm MgCl 2 , 0.06 mm EDTA, 2.3 mm DTT, 0.03% NP40, and a protease inhibitor cocktail (Roche) and with either polyclonal anti-Egr2 antibody (BabCO) or cold competitor double-stranded oligonucleotides (mutant and wt sequences are shown in Figure 5c ). The appropriate 32 P-labeled double-stranded wt oligonucleotides were added before incubation for 30 min at room temperature. Each sample was electrophoresed in a native 5% PAGE using 0.5 Â TBE buffer. The gels were dried and exposed for autoradiography at À801C.
